Key Findings
The research group led by Ryusaku Matsumoto and Takuya Yamamoto has developed a high-efficiency method for creating hypothalamic-pituitary organoids from human iPS cells. By adjusting the composition of feeder cells used during the maintenance culture of iPS cells, the team successfully optimized the ratio of hypothalamic cells to oral ectoderm cells, thereby increasing the differentiation efficiency into LHX3+ pituitary progenitor cells.
Technical Details
The study identified that the type of feeder cell influences differentiation preference: iPS cells cultured with SNL feeder cells showed a preference for non-neural ectoderm (resulting in more oral ectoderm cells), while those cultured with mouse embryonic fibroblasts (MEF) preferred neural ectoderm (resulting in more hypothalamic cells). To balance these populations, the researchers tested a mixture of the two. They found that using a mixed feeder cell layer with an SNL:MEF ratio between 3:1 and 1:1 significantly improved the induction of pituitary progenitor cells.
Additionally, the team addressed the labor-intensive nature of the process, which typically requires daily medium exchanges over 2–3 months. By replacing basic fibroblast growth factor (bFGF) with a stable mutant (FGF2-G3), they reduced medium exchange frequency to three times per week. This led to the establishment of a “Weekend-free” protocol that eliminates the need for weekend work while maintaining differentiation efficiency and showing a trend of increased ACTH secretion.
Background & Context
The pituitary gland develops from the oral ectoderm through critical cell-cell interactions with the adjacent hypothalamus. While iPS-derived organoids can reproduce these interactions and produce functional hormone-secreting cells, previous methods suffered from inconsistent efficiency across different cell lines and high operational burdens on researchers.
Significance & Outlook
This optimized induction method simplifies the production of three-dimensional tissue models that mimic the development and interaction of the hypothalamus and pituitary gland. These results, published in Stem Cell Reports on November 5, 2026, are expected to expand applications in the study of pituitary diseases and the development of regenerative medicine.
Source: https://www.cira.kyoto-u.ac.jp/j/pressrelease/news/261106-010000.html
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime



